{
    "organizations": [],
    "uuid": "bd8ba0b7c0033e1e2679de96689c7d617df449e1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/juno-ma-celgene/celgene-to-buy-remaining-stake-in-juno-for-9-billion-idUSL4N1PH3WH",
    "ord_in_thread": 0,
    "title": "Celgene to buy remaining stake in Juno for $9 billion",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 22 (Reuters) - Celgene Corp said on Monday it agreed to buy rest of Juno Therapeutics Inc for about $9 billion in cash to gain access to Junoâ€™s pipeline of CAR-T cancer drugs.\nCelgene already owns 9.7 percent in Juno and will offer $87 per share.\nReporting by Tamara Mathias in Bengaluru; Editing by Arun Koyyur\n ",
    "published": "2018-01-22T19:40:00.000+02:00",
    "crawled": "2018-01-23T17:55:21.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "celgene",
        "corp",
        "said",
        "monday",
        "agreed",
        "buy",
        "rest",
        "juno",
        "therapeutic",
        "inc",
        "billion",
        "cash",
        "gain",
        "access",
        "juno",
        "pipeline",
        "cancer",
        "drug",
        "celgene",
        "already",
        "owns",
        "percent",
        "juno",
        "offer",
        "per",
        "share",
        "reporting",
        "tamara",
        "mathias",
        "bengaluru",
        "editing",
        "arun",
        "koyyur"
    ]
}